恆大汽車(00708.HK):引入紐頓有效解決資金難題 助拓海外市場
恆大汽車(00708.HK)宣布引入紐頓集團(NWTN.US)為戰略投資者,向其發行61.77億股新股,涉及金額約38.9億元。恆大汽車表示,紐頓集團是一家先鋒綠色能源企業,亦是阿聯酋新能源在美國上市的第一家企業,在阿布扎比擁有整車組裝工廠,此次牽手中東資本預期將有效解決公司發展所面臨的資金難題。
該公司強調將憑藉技術積累、智能化製造基地、產品品質以及全球化供應鏈體系,全力推進「恆馳5」生產銷售,迅速佔領市場,並進一步推進「恆馳6」及「恆馳7」等新車型的研發及量產;同時亦會在中東投資方支持下,利用紐頓在中東及北非等關鍵市場的高效覆蓋,全力開拓海外市場。(gc/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.